Join Meeting Now

Your data is secure and never shared.

Middle East
July 2026

GCC Dietary Supplements Market Size, Share, Trends & Forecast, By Product Type, Form & Distribution Channel, 2026–2031

2031

The GCC Dietary Supplements Market worth USD 1,904 million in 2025 is growing at a CAGR of 10.70% to reach USD 3,505 million by 2031. Haleon, Nestlé Health Science, Abbott Laboratories, Herbalife and Amway are the major companies operating in this market.

Report Details

Base Year

2025

Pages

92

Region

Middle East

Author

Ken Research

Product Code
KR-RPT-V02-04169

CHAPTER 1 - MARKET SUMMARY

Market Overview

The GCC Dietary Supplements Market operates through international brand owners, regional importers, licensed distributors, pharmacy chains, specialist nutrition retailers and rapidly expanding e-commerce platforms. Demand is supported by 61.5 million residents in 2024 and a large expatriate workforce with diverse nutritional preferences. Repeat purchasing, preventive-health positioning and category expansion beyond basic multivitamins make customer retention and portfolio breadth central commercial levers.

Saudi Arabia is the largest demand and distribution hub, supported by an estimated population of 35.3 million in 2024, including 15.7 million non-Saudi residents. Riyadh, Jeddah and the Eastern Province concentrate pharmacy networks, modern retail and specialist fitness channels. The UAE is the primary regional launch platform for international premium brands because Dubai combines re-export infrastructure, tourism demand and high digital-retail adoption.

Market Value

USD 1,904 million

2025

Dominant Region

Saudi Arabia

2025

Dominant Segment

Vitamins and Minerals

fastest growing, 2025

Total Number of Players

185

Future Outlook

The GCC Dietary Supplements Market is projected to increase from USD 1,904 Mn in 2025 to USD 3,505 Mn by 2031, representing a forecast CAGR of 10.70%. This outlook is stronger than the 7.88% historical CAGR recorded during 2020–2025 because market growth is shifting from basic multivitamin penetration toward premium immunity, sports nutrition, digestive health, beauty-from-within and healthy-aging products. Higher digital availability, improved consumer education and broader pharmacist-led recommendations should expand purchase frequency. Value growth is expected to exceed pack-volume growth as clinically positioned formulations, branded ingredient systems and convenient gummies command higher average selling prices.

Saudi Arabia will generate the largest incremental revenue pool because of its population scale, pharmacy expansion and wellness-sector investment. The UAE will remain the leading premium and digital-commerce market, while Kuwait and Qatar will provide attractive per-capita spending. Forecast execution depends on compliant health claims, ingredient registration, supply resilience and consumer trust. GSO alignment can lower duplication, although national approval requirements will continue to shape launch sequencing. The base forecast assumes 8.20% annual pack-volume growth and approximately 2.30% annual price and mix improvement. A constrained scenario produces USD 3,090 Mn by 2031, while accelerated premiumization supports USD 3,875 Mn.

10.70%

Forecast CAGR

$3,505 Mn

2030 Projection

Base Year

2025

Historical Period

2020–2025

Forecast Period

2026–2031

Historical CAGR

7.88%

CHAPTER 2 - SCOPE OF REPORT

Scope of the Market

Click to Explore Interactive Mind Map

CHAPTER 3 - Key Stakeholders

Key Target Audience

Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.

Investors

CAGR, category margins, recurring revenue, regulatory risk, exits

Corporates

portfolio gaps, pricing, localization, claims compliance, partnerships

Government

product safety, local manufacturing, nutrition policy, resilience

Operators

registration, inventory turns, fulfilment, assortment, customer retention

Financial institutions

working capital, acquisition finance, covenants, demand stability

What You'll Gain

  • Market sizing and trajectory
  • Regulatory pathway mapping
  • Consumer demand indicators
  • Segment profit-pool analysis
  • Competitive landscape shortlist
  • Investment risk priorities

80+

Pages of insights

CHAPTER 4 - Market Size & Growth

Market Size, Growth Forecast and Trends

This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.

Historical & Projected Market Size ($ Million)

Year-over-Year Growth Rate (%)

Market Value vs Volume Growth (%)

Historical Market Performance (2020–2025)

Historical growth accelerated after the 2020 disruption as consumers retained immunity, vitamin D and general-wellness purchasing habits. The market's lowest annual expansion was 6.5% in 2021, while the 2025 inflection reached 10.7%. Pack volume increased from 58.6 million units in 2020 to 79.1 million units in 2025, and average retail value per pack advanced from USD 22.24 to USD 24.07. Saudi Arabia and the UAE accounted for most incremental consumption because they combine population scale, modern pharmacies and strong digital retail. The 2024 external benchmark of USD 1.72 Bn anchors the base-year progression.

Forecast Market Outlook (2026–2031)

Forecast growth is expected to remain value-led, with pack volume reaching 126.9 million units by 2031 and average retail value increasing to USD 27.62 per pack. Premium gummies, women's health, sports recovery, probiotics and practitioner-grade formulations will support mix improvement. Online discovery and subscription purchasing will improve access outside major metropolitan pharmacy clusters. Regulatory harmonization under GSO standards should reduce some formulation duplication, although local registration remains necessary. The forecast assumes continued non-oil consumption growth and stable import availability. IMF analysis identifies non-hydrocarbon activity as the GCC's principal growth engine, supporting discretionary health and wellness expenditure.

CHAPTER 5 - Market Data

Market Breakdown

The market is transitioning from low-frequency multivitamin purchasing toward recurring category participation across immunity, sports performance, digestive wellness and healthy aging. The KPI trajectory highlights improving unit demand, premiumization and digital-channel scalability relevant to manufacturers, distributors and investors.

Market Breakdown

Historical Data (2020-2024) • Base Data (2025) • Forecast Data (2026-2031)

Year
Market Size (USD Mn)
YoY Growth (%)
Consumer Packs Sold (Mn)
Average Retail Price per Pack (USD)
Online Channel Share (%)
Period
2020$1,303 Mn+-58.622.24
$#%
Forecast
2021$1,388 Mn+6.5%61.622.53
$#%
Forecast
2022$1,492 Mn+7.5%65.322.85
$#%
Forecast
2023$1,608 Mn+7.8%69.423.17
$#%
Forecast
2024$1,720 Mn+7.0%73.223.50
$#%
Forecast
2025$1,904 Mn+10.7%79.124.07
$#%
Forecast
2026$2,108 Mn+10.7%85.624.63
$#%
Forecast
2027$2,334 Mn+10.7%92.625.21
$#%
Forecast
2028$2,584 Mn+10.7%100.225.79
$#%
Forecast
2029$2,860 Mn+10.7%108.426.38
$#%
Forecast
2030$3,166 Mn+10.7%117.326.99
$#%
Forecast
2031$3,505 Mn+10.7%126.927.62
$#%
Forecast

Consumer Packs Sold

79.1 million packs, 2025, GCC. Higher repeat purchasing increases manufacturing throughput and distributor working-capital requirements. GCC population reached 61.5 million in 2024, supporting a broad addressable consumer base.

Average Retail Price per Pack

USD 24.07, 2025, GCC. Premium formulations, gummies and clinically positioned products expand gross-profit pools. Global wellness demand is shifting toward science-backed premium supplements, reinforcing value over commodity positioning.

Online Channel Share

19%, 2025, GCC. Digital channels improve assortment reach and customer lifetime value through replenishment reminders. Internet usage reached 98% in early 2024 across the GCC digital environment, with mobile broadband subscriptions at 116.8 per 100 people.

CHAPTER 6 - Segmentation

Market Segmentation Framework

Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.

No of Segments

7

Dominant Segment

Product Type

Fastest Growing Segment

Form

Product Type

Vitamins and Minerals
$%
Herbal and Botanical Supplements
$%
Proteins and Amino Acids
$%
Specialty Supplements
$%

Form

Tablets and Capsules
$%
Powders and Sachets
$%
Gummies and Chewables
$%
Liquids and Shots
$%

Health Benefit

General Wellness and Immunity
$%
Sports and Performance
$%
Bone and Joint Health
$%
Digestive and Metabolic Health
$%

Consumer Group

Adults
$%
Children and Adolescents
$%
Women's Health
$%
Older Adults and Active Aging
$%

Price Tier

Value
$%
Mid-Market
$%
Premium
$%
Clinical and Practitioner Grade
$%

Distribution Channel

Pharmacies and Drugstores
$%
Hypermarkets and Supermarkets
$%
E-Commerce Platforms
$%
Specialty and Direct Selling
$%

Geography

Saudi Arabia
$%
United Arab Emirates
$%
Kuwait and Qatar
$%
Oman and Bahrain
$%

Key Segmentation Takeaways

Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.

Product Type

Product Type remains the dominant dimension because vitamins and minerals represent the broadest entry point for daily supplementation, pharmacist recommendations and family purchasing. Multivitamin and mineral blends generate recurring volume, while herbal products, collagen, probiotics and omega fatty acids provide higher-value adjacent profit pools. Portfolio breadth enables suppliers to serve mass, premium and practitioner-led demand without relying on one therapeutic positioning.

Form

Form is the fastest-growing dimension as consumers move beyond conventional tablets toward gummies, sachets, powders and functional shots. Gummies and chewables reduce pill fatigue and improve appeal among children and younger adults, while single-serve powders suit sports and travel occasions. Manufacturers with taste-masking, stability, heat-resistant packaging and sugar-reduction capabilities can capture stronger margins and higher repeat purchase rates.

CHAPTER 7 - Regional Analysis

Regional Analysis

Saudi Arabia ranks first among GCC dietary supplement markets because its population and pharmacy footprint outweigh the higher per-capita spending recorded in the UAE, Kuwait and Qatar. The UAE remains the region's premium launch and e-commerce hub, while smaller Gulf markets provide concentrated opportunities for specialist and practitioner-grade products.

Saudi Arabia Ranking

1st

Saudi Arabia Market Size (2025)

USD 890 Mn

Saudi Arabia CAGR (2026–2031)

11.20%

Regional Analysis (Current Year)

Regional Analysis Comparison

MetricSaudi ArabiaUnited Arab EmiratesKuwaitQatarOmanBahrain
Market Size (USD Mn, 2025)89055017512011059
CAGR (2026–2031)11.2%10.8%8.8%9.2%8.4%8.6%
Adult Obesity Prevalence (%)35%32%38%35%27%30%
Digital Retail Readiness Index (100)889691948290

Market Position

Saudi Arabia ranks first with USD 890 Mn in 2025, supported by 35.3 million residents and the region's largest addressable pharmacy and wellness consumer base.

Growth Advantage

Saudi Arabia's 11.2% forecast CAGR exceeds Kuwait's 8.8% and Oman's 8.4%, positioning the Kingdom as the principal incremental revenue pool for regional manufacturers and distributors.

Competitive Strengths

Population scale, high obesity-related wellness demand and expanding non-oil consumption strengthen Saudi Arabia's position; non-hydrocarbon investment represents approximately 85% to 90% of national gross capital formation.

CHAPTER 8 - INDUSTRY ANALYSIS

Growth Drivers, Challenges & Opportunities

Comprehensive analysis of key factors shaping the GCC Dietary Supplements Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.

Growth Drivers

Preventive Wellness and Lifestyle-Disease Burden

  • Kuwait recorded 38% adult obesity prevalence (2023, WHO/GCC), supporting demand for metabolic-health, fibre and weight-management formulations while raising scrutiny of unsupported claims.
  • Saudi Arabia and Qatar each recorded approximately 35% adult obesity prevalence (2023, WHO/GCC), strengthening the commercial case for pharmacist-led wellness programmes and evidence-backed nutritional support.
  • The UAE recorded approximately 32% adult obesity prevalence (2023, WHO/GCC), creating demand for premium metabolic, sports and personalized nutrition products across affluent urban consumer groups.

Population Expansion and Consumer Purchasing Power

  • Saudi Arabia's population reached 35.3 million (2024, Saudi Arabia), providing the largest regional consumer base and justifying country-specific product portfolios, local warehousing and field-sales investment.
  • Non-Saudi residents represented 44.4% of Saudi Arabia's population (2024, Saudi Arabia), increasing demand for internationally recognized brands and culturally diverse supplement formats.
  • GCC real GDP reached approximately USD 1,825.1 Bn (2024, GCC), providing the income and retail infrastructure required for discretionary preventive-health purchasing.

Digital Commerce and Mobile-First Discovery

  • Mobile broadband subscriptions reached 116.8 per 100 people (2024, GCC digital environment), allowing brands to use app-based subscriptions, performance marketing and personalized replenishment.
  • Mobile-phone ownership approached 98.5% (2024, GCC digital environment), shifting competitive advantage toward brands with Arabic content, transparent ingredient information and rapid digital fulfilment.
  • Online-channel participation is projected to reach 31% of market value (2031, GCC estimate), expanding addressable assortment while increasing price transparency and customer-acquisition competition.

Market Challenges

Country-Level Registration and Compliance Complexity

  • GSO 2571:2021 covers more than 12 ingredient categories (2021, GCC), but national regulators determine classification and dossier acceptance, requiring specialized regulatory capability.
  • Saudi registration guidance requires structured safety, quality and product documentation for herbal and health products (2019, Saudi Arabia), increasing time-to-market for complex formulations.
  • The UAE maintains a registered medical-product directory updated on 2 May 2026 (UAE), reinforcing the need for active registration maintenance and local responsible entities.

Import Dependence and Supply-Chain Exposure

  • Saudi vitamin A imports totalled 40,473 kilograms (2023, Saudi Arabia), demonstrating dependence on international ingredient suppliers and long replenishment cycles.
  • Switzerland supplied approximately 61% of Saudi vitamin A import value (2023, Saudi Arabia), indicating concentration risk for specific high-value ingredients.
  • Saudi vitamin E imports reached USD 3.94 Mn (2023, Saudi Arabia), with Switzerland and Germany forming the principal sources, creating supplier-diversification requirements.

Consumer Trust and Claims Substantiation

  • Nutrition labelling is controlled under GSO 2233:2021 (2021, GCC), raising compliance expectations for nutrient quantities, serving sizes and comparative claims.
  • Global consumers increasingly favour science-backed formulations, while reviewed mass-market vitamin brands generated approximately USD 1.25 Bn (2025, global portfolio), illustrating the strategic pressure to differentiate on evidence.
  • Products making complex health claims face higher documentation and surveillance costs, making regulatory evidence capability (2025, GCC) a material barrier for small entrants and private labels.

Market Opportunities

Practitioner-Grade and Science-Backed Formulations

  • The monetizable angle is higher gross profit from branded ingredients, clinical positioning and targeted dosage systems, supported by approximately 2.3% annual ASP growth (2026–2031, GCC estimate).
  • Pharmacy chains, practitioner networks and science-led brands benefit from consumers prioritizing substantiation over commodity formulations, a shift visible in the USD 193 Bn global supplement market (2024, global).
  • Opportunity realization requires compliant local claims dossiers and pharmacist education aligned with GSO health-claim requirements (2013, GCC).

Regional Contract Manufacturing and Private Labels

  • Contract manufacturers can monetize formulation, tableting, encapsulation, gummy production, sachet filling and Arabic-compliant packaging across a projected 47.8 million-pack incremental pool (2025–2031, GCC estimate).
  • Pharmacy groups and grocery retailers benefit through private-label margin capture, faster replenishment and exclusive assortments tailored to six GCC national markets (2025, GCC).
  • Investment requires accredited testing, stability validation and compliance with GSO 2571:2021 (2021, GCC) across permitted supplement ingredients and formats.

Digital Subscriptions and Personalized Wellness

  • Brands can monetize bundles, replenishment plans and personalized routines across a population with 98% internet usage (2024, GCC digital environment).
  • Consumers, pharmacies and digital-health platforms benefit from improved adherence, transparent ingredient comparison and lower fulfilment friction supported by 116.8 mobile broadband subscriptions per 100 people (2024).
  • Personalization requires consent-based data management, qualified recommendation logic and integration with licensed fulfilment channels before the projected USD 1,086 Mn online revenue pool (2031, GCC estimate) can be fully captured.

CHAPTER 9 - Competitive Landscape

Competitive Landscape Overview

The GCC market is fragmented across global wellness brands, pharmaceutical nutrition companies, specialist supplement manufacturers and private-label retailers. Regulatory approvals, trusted distribution, product evidence and pharmacy access represent the principal entry barriers.

Market Share Distribution

Haleon plc
Nestlé Health Science
Abbott Laboratories
Bayer AG

Top 5 Players

1
Haleon plc
!$*
2
Nestlé Health Science
^&
3
Abbott Laboratories
#@
4
Bayer AG
$
5
Herbalife Ltd.
&@$
Combined Share$%

Market Dynamics

Local Players70%
Regional/Int'l30%

8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.

Company Profiles (Top 10 Players)
Company Name
Market Share
Headquarters
Founding Year
Core Market Focus
Haleon plc
-Weybridge, United Kingdom2022Multivitamins, minerals and consumer wellness supplements
Nestlé Health Science
-Vevey, Switzerland2011Vitamins, minerals, healthy aging and specialized nutrition
Abbott Laboratories
-Abbott Park, United States1888Adult, pediatric and condition-specific nutritional products
Bayer AG
-Leverkusen, Germany1863Women's health, vitamins and consumer-health supplements
Herbalife Ltd.
-Los Angeles, United States1980Weight management, sports nutrition and direct selling
Amway Corporation
-Ada, United States1959Vitamins, botanicals and direct-selling wellness products
Jamieson Wellness Inc.
-Toronto, Canada1922Vitamins, minerals, probiotics and specialty supplements
GNC Holdings LLC
-Pittsburgh, United States1935Sports nutrition, vitamins and specialty retail
NOW Health Group
-Bloomingdale, United States1968Natural supplements, sports nutrition and functional wellness
Vitabiotics Ltd.
-London, United Kingdom1971Life-stage vitamins, women's health and family nutrition

Cross Comparison Parameters

The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.

Analysis Covered

Market Share Analysis:

Compares estimated category revenue concentration across leading GCC supplement companies

Cross Comparison Matrix:

Benchmarks distribution, portfolio, growth and profitability across selected competitors

SWOT Analysis:

Evaluates brand strength, compliance exposure, innovation capability and vulnerabilities

Pricing Strategy Analysis:

Assesses value, mainstream, premium and practitioner-grade price positioning strategies

Company Profiles:

Reviews ownership, regional presence, portfolio priorities and channel capabilities

CHAPTER 10 - REPORT TOC

Table of Contents

92Pages
34Chapters
10Companies Profiled
7Segmentation Types
Phase 1

Market Assessment Phase

11

Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.

Phase 2

Go-To-Market Strategy Phase

15 chapters

Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.

Phase 3

Survey Phase

8 chapters

Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers.

Complete Report Coverage

201+ detailed sections covering every aspect of the market

143

Assessment Sections

58

Strategy Sections

CHAPTER 11 - Our Approach

Research Methodology

Desk Research

  • Mapped GCC supplement registration frameworks
  • Reviewed vitamin and ingredient trade flows
  • Analyzed pharmacy and online assortments
  • Benchmarked category prices and pack formats

Primary Research

  • Interviewed regional regulatory affairs directors
  • Engaged pharmacy category procurement managers
  • Consulted supplement distributor commercial directors
  • Surveyed contract manufacturing operations leaders

Validation and Triangulation

  • Validated findings across 286 respondents
  • Reconciled supplier and channel revenues
  • Cross-checked volume and retail pricing
  • Tested country-level consumption plausibility

CHAPTER 12 - FAQ

FAQs

Still have questions?

Our research team is here to help you find the right solution

Contact Research Team

Want the full report and an analyst walkthrough?

Unlock the complete dataset, segmentation cuts, and competitive analysis—plus a discovery call that maps insights to your go-to-market priorities.

;GCC Dietary Supplements Market Share, Companies & Trends Report 2026-2031